INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
SEC FORM 4/Grant or awardVerified data

Schoenherr Thomas Edward reported TEM

CEO, Diagnostics · Tempus AI, Inc. · Class A Common Stock

Side
A
Value
—
Shares
13.6K
Price
—
Executed
May 4, 2026
Disclosed
May 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
May 4 executedMay 6, 2026 disclosed

TEM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+5 / 25

No reported dollar value · 14.4% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · TEM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    10
    ER
    Epstein David RDirector
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$27K
    370 sh
    Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    +2dSEC FORM 4

    Evidence

    0
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Grant or award · 10b5-1 plan
    A—
    100.0K sh
    Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    +2dSEC FORM 4

    Evidence

    3
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$5,943
    80 sh
    Nov 2, 2026Nov 4, 2026
    traded Nov 2, 2026
    +2dSEC FORM 4

    Evidence

    23
    SE
    Schoenherr Thomas EdwardCEO, Diagnostics
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$874K
    10.3K sh
    Sep 25, 2026Sep 29, 2026
    traded Sep 25, 2026
    +4dSEC FORM 4

    Evidence

    26
    BM
    Bartolucci Ryan MChief Accounting Officer
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$530K
    7,062 sh
    Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    +1dSEC FORM 4

    Evidence

    13
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$49K
    700 sh
    Sep 16, 2026Sep 18, 2026
    traded Sep 16, 2026
    +2dSEC FORM 4

    Evidence

    16
    PA
    Polovin AndrewEVP, Chief Legal Officer
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$221K
    2,951 sh
    Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    +1dSEC FORM 4

    Evidence

    20
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$65K
    1,000 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    27
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$810K
    13.0K sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    27
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$683K
    10.9K sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    27
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$376K
    5,900 sh
    Sep 1, 2026Sep 3, 2026
    traded Sep 1, 2026
    +2dSEC FORM 4

    Evidence

    27
    WN
    West NadjaDirector
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$207K
    3,000 sh
    Aug 28, 2026Sep 1, 2026
    traded Aug 28, 2026
    +4dSEC FORM 4

    Evidence

    30
    FR
    Fukushima RyanCEO, Data
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$1.00M
    14.3K sh
    Aug 21, 2026Aug 25, 2026
    traded Aug 21, 2026
    +4dSEC FORM 4

    Evidence

    16
    SE
    Schoenherr Thomas EdwardCEO, Diagnostics
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$189K
    2,694 sh
    Aug 21, 2026Aug 25, 2026
    traded Aug 21, 2026
    +4dSEC FORM 4

    Evidence

    19
    SE
    Schoenherr Thomas EdwardCEO, Diagnostics
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$180K
    2,994 sh
    Aug 19, 2026Aug 20, 2026
    traded Aug 19, 2026
    +1dSEC FORM 4

    Evidence

    19
    SE
    Schoenherr Thomas EdwardCEO, Diagnostics
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$54K
    900 sh
    Aug 19, 2026Aug 20, 2026
    traded Aug 19, 2026
    +1dSEC FORM 4

    Evidence

    23
    PA
    Polovin AndrewEVP, Chief Legal Officer
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$444K
    7,927 sh
    Aug 19, 2026Aug 20, 2026
    traded Aug 19, 2026
    +1dSEC FORM 4

    Evidence

    46
    BM
    Bartolucci Ryan MChief Accounting Officer
    TEMTempus AI, Inc.
    Open-market sale
    SELL$306K
    6,175 sh
    Aug 18, 2026Aug 20, 2026
    traded Aug 18, 2026
    +2dSEC FORM 4

    Evidence

    26
    RW
    Rogers James WilliamChief Financial Officer
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$1.12M
    22.5K sh
    Aug 18, 2026Aug 20, 2026
    traded Aug 18, 2026
    +2dSEC FORM 4

    Evidence

    16
    SE
    Schoenherr Thomas EdwardCEO, Diagnostics
    TEMTempus AI, Inc.
    Open-market sale · 10b5-1 plan
    SELL$5,647
    100 sh
    Aug 19, 2026Aug 20, 2026
    traded Aug 19, 2026
    +1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002113721-26-000004
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    May 4, 2026
    Published
    May 6, 2026
    Ingested by INSIDER
    Nov 5, 04:00 UTC
    Last re-read
    Nov 5, 04:00 UTC

    Extracted facts

    Filer
    Schoenherr Thomas Edward
    Role
    CEO, Diagnostics
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Tempus AI, Inc.
    Ticker
    TEM
    Shares
    13.6K
    Price per share
    $0
    Execution date (reported)
    May 4, 2026
    Owned after transaction
    108.6K shares
    Days from execution to publication
    2

    What this establishes

    Schoenherr Thomas Edward filed this Form 4 reporting a grant or award of TEM on May 4, 2026. It became public on May 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CEO, Diagnostics
    Schoenherr Thomas Edwardcik:0002113721
    Issuer
    Tempus AI, Inc.cik:0001717115

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.